Cover Page
Cover Page - shares | 9 Months Ended | |
Mar. 31, 2022 | Apr. 29, 2022 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2022 | |
Document Transition Report | false | |
Entity File Number | 001-36348 | |
Entity Registrant Name | PAYLOCITY HOLDING CORPORATION | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 46-4066644 | |
Entity Address, Address Line One | 1400 American Lane | |
Entity Address, City or Town | Schaumburg | |
Entity Address, State or Province | IL | |
Entity Address, Postal Zip Code | 60173 | |
City Area Code | 847 | |
Local Phone Number | 463-3200 | |
Title of 12(b) Security | Common Stock, par value $0.001 per share | |
Trading Symbol | PCTY | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 55,124,761 | |
Entity Central Index Key | 0001591698 | |
Current Fiscal Year End Date | --06-30 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
Unaudited Consolidated Balance
Unaudited Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2022 | Jun. 30, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 96,465 | $ 202,287 |
Corporate investments | 0 | 4,456 |
Accounts receivable, net | 17,794 | 6,267 |
Deferred contract costs | 54,735 | 44,230 |
Prepaid expenses and other | 23,430 | 15,966 |
Total current assets before funds held for clients | 192,424 | 273,206 |
Funds held for clients | 4,324,567 | 1,759,677 |
Total current assets | 4,516,991 | 2,032,883 |
Capitalized internal-use software, net | 57,713 | 45,018 |
Property and equipment, net | 64,004 | 59,835 |
Operating lease right-of-use assets | 50,808 | 43,984 |
Intangible assets, net | 48,245 | 13,027 |
Goodwill | 102,183 | 33,650 |
Long-term deferred contract costs | 209,580 | 170,663 |
Long-term prepaid expenses and other | 7,910 | 4,223 |
Deferred income tax assets | 21,804 | 11,602 |
Total assets | 5,079,238 | 2,414,885 |
Current liabilities: | ||
Accounts payable | 5,051 | 4,230 |
Accrued expenses | 108,820 | 103,109 |
Total current liabilities before client fund obligations | 113,871 | 107,339 |
Client fund obligations | 4,324,567 | 1,759,677 |
Total current liabilities | 4,438,438 | 1,867,016 |
Long-term operating lease liabilities | 71,178 | 67,201 |
Other long-term liabilities | 2,422 | 1,958 |
Deferred income tax liabilities | 1,781 | 1,780 |
Total liabilities | 4,513,819 | 1,937,955 |
Stockholders’ equity: | ||
Preferred stock, $0.001 par value, 5,000 authorized, no shares issued and outstanding at June 30, 2021 and March 31, 2022 | 0 | 0 |
Common stock, $0.001 par value, 155,000 shares authorized at June 30, 2021 and March 31, 2022; 54,594 shares issued and outstanding at June 30, 2021 and 55,120 shares issued and outstanding at March 31, 2022 | 55 | 55 |
Additional paid-in capital | 256,204 | 241,718 |
Retained earnings | 310,722 | 235,091 |
Accumulated other comprehensive income (loss) | (1,562) | 66 |
Total stockholders' equity | 565,419 | 476,930 |
Total liabilities and stockholders’ equity | $ 5,079,238 | $ 2,414,885 |
Unaudited Consolidated Balanc_2
Unaudited Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands | Mar. 31, 2022 | Jun. 30, 2021 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized (in shares) | 5,000 | 5,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 155,000 | 155,000 |
Common stock, shares issued (in shares) | 55,120 | 54,594 |
Common stock, shares outstanding (in shares) | 55,120 | 54,594 |
Unaudited Consolidated Statemen
Unaudited Consolidated Statements of Operations and Comprehensive Income - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Revenues: | ||||
Recurring and other revenue | $ 244,962 | $ 184,927 | $ 620,827 | $ 465,195 |
Interest income on funds held for clients | 1,008 | 1,126 | 2,877 | 2,981 |
Total revenues | 245,970 | 186,053 | 623,704 | 468,176 |
Cost of revenues | 75,538 | 57,326 | 209,608 | 160,248 |
Gross profit | 170,432 | 128,727 | 414,096 | 307,928 |
Operating expenses: | ||||
Sales and marketing | 52,752 | 40,055 | 154,856 | 115,504 |
Research and development | 25,670 | 18,458 | 74,024 | 56,443 |
General and administrative | 44,632 | 31,071 | 119,448 | 87,038 |
Total operating expenses | 123,054 | 89,584 | 348,328 | 258,985 |
Operating income | 47,378 | 39,143 | 65,768 | 48,943 |
Other expense | (311) | (207) | (800) | (843) |
Income before income taxes | 47,067 | 38,936 | 64,968 | 48,100 |
Income tax expense (benefit) | 12,221 | 2,102 | (10,663) | (10,836) |
Net income | 34,846 | 36,834 | 75,631 | 58,936 |
Other comprehensive loss, net of tax | (1,218) | (126) | (1,628) | (536) |
Comprehensive income | $ 33,628 | $ 36,708 | $ 74,003 | $ 58,400 |
Net income per share: | ||||
Basic (in dollars per share) | $ 0.63 | $ 0.68 | $ 1.38 | $ 1.09 |
Diluted (in dollars per share) | $ 0.62 | $ 0.65 | $ 1.34 | $ 1.05 |
Weighted-average shares used in computing net income per share: | ||||
Basic (in shares) | 55,114 | 54,415 | 54,996 | 54,244 |
Diluted (in shares) | 56,367 | 56,414 | 56,437 | 56,338 |
Unaudited Consolidated Statem_2
Unaudited Consolidated Statement of Changes in Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) |
Beginning balance (in shares) at Jun. 30, 2020 | 53,792 | ||||
Beginning balance at Jun. 30, 2020 | $ 392,908 | $ 54 | $ 227,907 | $ 164,272 | $ 675 |
Increase (Decrease) in Stockholders' Equity | |||||
Stock-based compensation | 48,896 | 48,896 | |||
Stock options exercised (in shares) | 338 | ||||
Stock options exercised | 2,477 | 2,477 | |||
Issuance of common stock upon vesting of restricted stock units (in shares) | 622 | ||||
Issuance of common stock under employee stock purchase plan (in shares) | 60 | ||||
Issuance of common stock under employee stock purchase plan | 6,100 | 6,100 | |||
Shares withheld in net settlement for taxes and/or exercise price (in shares) | (361) | ||||
Net settlement for taxes and/or exercise price related to equity awards | (54,172) | (54,172) | |||
Unrealized losses on securities, net of tax | (536) | (536) | |||
Net income | 58,936 | 58,936 | |||
Ending balance (in shares) at Mar. 31, 2021 | 54,451 | ||||
Ending balance at Mar. 31, 2021 | 454,609 | $ 54 | 231,208 | 223,208 | 139 |
Beginning balance (in shares) at Dec. 31, 2020 | 54,370 | ||||
Beginning balance at Dec. 31, 2020 | 408,218 | $ 54 | 221,525 | 186,374 | 265 |
Increase (Decrease) in Stockholders' Equity | |||||
Stock-based compensation | 16,663 | 16,663 | |||
Stock options exercised (in shares) | 104 | ||||
Stock options exercised | 545 | 545 | |||
Issuance of common stock upon vesting of restricted stock units (in shares) | 14 | ||||
Shares withheld in net settlement for taxes and/or exercise price (in shares) | (37) | ||||
Net settlement for taxes and/or exercise price related to equity awards | (7,525) | (7,525) | |||
Unrealized losses on securities, net of tax | (126) | (126) | |||
Net income | 36,834 | 36,834 | |||
Ending balance (in shares) at Mar. 31, 2021 | 54,451 | ||||
Ending balance at Mar. 31, 2021 | $ 454,609 | $ 54 | 231,208 | 223,208 | 139 |
Beginning balance (in shares) at Jun. 30, 2021 | 54,594 | 54,594 | |||
Beginning balance at Jun. 30, 2021 | $ 476,930 | $ 55 | 241,718 | 235,091 | 66 |
Increase (Decrease) in Stockholders' Equity | |||||
Stock-based compensation | 75,726 | 75,726 | |||
Stock options exercised (in shares) | 204 | ||||
Stock options exercised | 1,972 | 1,972 | |||
Issuance of common stock upon vesting of restricted stock units (in shares) | 549 | ||||
Issuance of common stock under employee stock purchase plan (in shares) | 53 | ||||
Issuance of common stock under employee stock purchase plan | 7,216 | 7,216 | |||
Shares withheld in net settlement for taxes and/or exercise price (in shares) | (280) | ||||
Net settlement for taxes and/or exercise price related to equity awards | (70,428) | (70,428) | |||
Unrealized losses on securities, net of tax | (1,628) | (1,628) | |||
Net income | $ 75,631 | 75,631 | |||
Ending balance (in shares) at Mar. 31, 2022 | 55,120 | 55,120 | |||
Ending balance at Mar. 31, 2022 | $ 565,419 | $ 55 | 256,204 | 310,722 | (1,562) |
Beginning balance (in shares) at Dec. 31, 2021 | 55,105 | ||||
Beginning balance at Dec. 31, 2021 | 506,693 | $ 55 | 231,106 | 275,876 | (344) |
Increase (Decrease) in Stockholders' Equity | |||||
Stock-based compensation | 26,498 | 26,498 | |||
Stock options exercised (in shares) | 9 | ||||
Stock options exercised | 160 | 160 | |||
Issuance of common stock upon vesting of restricted stock units (in shares) | 13 | ||||
Shares withheld in net settlement for taxes and/or exercise price (in shares) | (7) | ||||
Net settlement for taxes and/or exercise price related to equity awards | (1,560) | (1,560) | |||
Unrealized losses on securities, net of tax | (1,218) | (1,218) | |||
Net income | $ 34,846 | 34,846 | |||
Ending balance (in shares) at Mar. 31, 2022 | 55,120 | 55,120 | |||
Ending balance at Mar. 31, 2022 | $ 565,419 | $ 55 | $ 256,204 | $ 310,722 | $ (1,562) |
Unaudited Consolidated Statem_3
Unaudited Consolidated Statements of Cash Flows $ in Thousands | 9 Months Ended | |
Mar. 31, 2022USD ($) | Mar. 31, 2021USD ($) | |
Cash flows from operating activities: | ||
Net income | $ 75,631 | $ 58,936 |
Adjustments to reconcile net income to net cash provided by operating activities | ||
Stock-based compensation expense | 70,197 | 46,947 |
Depreciation and amortization expense | 36,419 | 32,070 |
Deferred income tax benefit | (10,882) | (10,656) |
Provision for credit losses | 238 | 213 |
Net accretion of discounts and amortization of premiums on available-for-sale securities | 342 | 315 |
Amortization of debt issuance costs | 136 | 127 |
Other | 286 | 545 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (9,654) | (4,495) |
Deferred contract costs | (49,205) | (39,621) |
Prepaid expenses and other | (9,418) | (2,531) |
Accounts payable | 141 | 1,592 |
Accrued expenses and other | 1,163 | 2,318 |
Net cash provided by operating activities | 105,394 | 85,760 |
Cash flows from investing activities: | ||
Purchases of available-for-sale securities | (215,538) | 0 |
Proceeds from sales and maturities of available-for-sale securities | 85,875 | 82,488 |
Capitalized internal-use software costs | (26,285) | (21,664) |
Purchases of property and equipment | (15,355) | (8,155) |
Acquisitions of businesses, net of cash acquired | (107,576) | (14,992) |
Other investing activities | (2,500) | 0 |
Net cash provided by (used in) investing activities | (281,379) | 37,677 |
Cash flows from financing activities: | ||
Net change in client fund obligations | 2,564,829 | 724,610 |
Borrowings under credit facility | 50,000 | 0 |
Repayment of credit facility | (50,000) | (100,000) |
Proceeds from exercise of stock options | 0 | 146 |
Proceeds from employee stock purchase plan | 7,216 | 6,100 |
Taxes paid related to net share settlement of equity awards | (68,509) | (51,828) |
Payment of debt issuance costs | (64) | (56) |
Net cash provided by financing activities | 2,503,472 | 578,972 |
Net change in cash, cash equivalents and funds held for clients' cash and cash equivalents | 2,327,487 | 702,409 |
Cash, cash equivalents and funds held for clients' cash and cash equivalents—beginning of period | 1,945,881 | 1,492,133 |
Cash, cash equivalents and funds held for clients' cash and cash equivalents—end of period | 4,273,368 | 2,194,542 |
Supplemental Disclosure of Non-Cash Investing and Financing Activities | ||
Purchases of property and equipment, accrued but not paid | 1,251 | 0 |
Liabilities assumed for acquisitions | 4,470 | 281 |
Supplemental Disclosure of Cash Flow Information | ||
Cash paid for interest | 257 | 820 |
Refunds received for income taxes | (115) | (222) |
Reconciliation of cash, cash equivalents and funds held for clients' cash and cash equivalents to the Consolidated Balance Sheets | ||
Cash and cash equivalents | 96,465 | 175,453 |
Funds held for clients' cash and cash equivalents | 4,176,903 | 2,019,089 |
Total cash, cash equivalents and funds held for clients' cash and cash equivalents | $ 4,273,368 | $ 2,194,542 |
Organization and Description of
Organization and Description of Business | 9 Months Ended |
Mar. 31, 2022 | |
Organization and Description of Business [Abstract] | |
Organization and Description of Business | (1) Organization and Description of Business |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | (2) Summary of Significant Accounting Policies (a) Basis of Presentation, Consolidation and Use of Estimates These unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these consolidated financial statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. (b) Interim Unaudited Consolidated Financial Information The accompanying unaudited consolidated financial statements and notes have been prepared in accordance with GAAP and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of the Company’s financial position, results of operations, changes in stockholders’ equity and cash flows. The results of operations for three and nine months ended March 31, 2022 are not necessarily indicative of the results for the full year or the results for any future periods. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes for the year ended June 30, 2021 included in the Company’s Annual Report on Form 10-K. (c) Income Taxes Income taxes are accounted for in accordance with ASC 740, Income Taxes, using the asset and liability method. The Company’s provision for income taxes is based on the annual effective rate method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes deferred tax assets to the extent that it believes that these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net-recorded amount, it would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. (d) Recently Issued Accounting Standards |
Revenue
Revenue | 9 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | (3) Revenue The Company derives its revenue from contracts predominantly from recurring and non-recurring service fees. While the majority of its agreements are generally cancellable by the client on 60 days’ notice or less, the Company also offers term agreements to its clients, which are generally two years in length. Recurring fees are derived from payroll, timekeeping, and HR-related cloud-based computing services. The majority of the Company’s recurring fees are satisfied over time as services are provided. The performance obligations related to payroll services are satisfied upon the processing of the client’s payroll with the fee charged and collected based on a per employee per payroll frequency fee. The performance obligations related to time and attendance services and HR related services are satisfied over time each month with the fee charged and collected based on a per employee per month fee. For subscription-based fees which can include payroll, time and attendance, and HR related services, the Company recognizes the applicable recurring fees over time each month with the fee charged and collected based on a per employee per month fee. Non-recurring service fees consist mainly of nonrefundable implementation fees, which involve setting the client up in, and loading data into, the Company’s cloud-based modules. These implementation activities are considered set-up activities. The Company has determined that the nonrefundable upfront fees provide certain clients with a material right to renew the contract. Disaggregation of revenue The following table disaggregates revenue by Recurring fees and Implementation services and other, which the Company believes depicts the nature, amount and timing of its revenue: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Recurring fees $ 178,711 $ 236,657 $ 448,864 $ 599,513 Implementation services and other 6,216 8,305 16,331 21,314 Total revenues from contracts $ 184,927 $ 244,962 $ 465,195 $ 620,827 Deferred revenue The timing of revenue recognition for recurring revenue is consistent with the timing of invoicing as they occur simultaneously based on the client’s payroll frequency or by month for subscription-based fees. As such, the Company does not recognize contract assets or liabilities related to recurring revenue. The nonrefundable upfront fees related to implementation services are invoiced with the client’s first payroll period. The Company defers and amortizes these nonrefundable upfront fees generally over a period up to 24 months based on the type of contract. The following table summarizes the changes in deferred revenue (i.e., contract liability) related to these nonrefundable upfront fees as follows: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Balance at beginning of the period $ 7,065 $ 9,341 $ 8,434 $ 8,734 Deferral of revenue 5,821 9,105 11,811 18,865 Revenue recognized (4,097) (6,044) (11,456) (15,197) Balance at end of the period $ 8,789 $ 12,402 $ 8,789 $ 12,402 Deferred revenue related to these nonrefundable upfront fees are recorded within Accrued expenses and Other long-term liabilities on the Unaudited Consolidated Balance Sheets. The Company expects to recognize these deferred revenue balances of $4,982 in fiscal 2022, $6,127 in fiscal 2023 and $1,293 in fiscal 2024 and thereafter. Deferred contract costs The Company defers certain selling and commission costs that meet the capitalization criteria under ASC 340-40. The Company also capitalizes certain costs to fulfill a contract related to its proprietary products if they are identifiable, generate or enhance resources used to satisfy future performance obligations and are expected to be recovered under ASC 340-40. Implementation fees are treated as nonrefundable upfront fees and the related implementation costs are required to be capitalized and amortized over the expected period of benefit, which is the period in which the Company expects to recover the costs and enhance its ability to satisfy future performance obligations. The Company utilizes the portfolio approach to account for both the cost of obtaining a contract and the cost of fulfilling a contract. These capitalized costs are amortized over the expected period of benefit, which has been determined to be over 7 years based on the Company’s average client life and other qualitative factors, including rate of technological changes. The Company does not incur any additional costs to obtain or fulfill contracts upon renewal. The Company recognizes additional selling and commission costs and fulfillment costs when an existing client purchases additional services. These additional costs only relate to the additional services purchased and do not relate to the renewal of previous services. The following tables present the deferred contract costs and the related amortization expense for these deferred contract costs: Three Months Ended March 31, 2021 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 125,817 $ 17,315 $ (7,390) $ 135,742 Costs to fulfill a contract 55,657 8,872 (2,607) 61,922 Total $ 181,474 $ 26,187 $ (9,997) $ 197,664 Three Months Ended March 31, 2022 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 155,564 $ 22,256 $ (9,182) $ 168,638 Costs to fulfill a contract 86,115 13,825 (4,263) 95,677 Total $ 241,679 $ 36,081 $ (13,445) $ 264,315 Nine Months Ended March 31, 2021 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 113,575 $ 43,026 $ (20,859) $ 135,742 Costs to fulfill a contract 44,468 24,376 (6,922) 61,922 Total $ 158,043 $ 67,402 $ (27,781) $ 197,664 Nine Months Ended March 31, 2022 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 145,718 $ 48,922 $ (26,002) $ 168,638 Costs to fulfill a contract 69,175 37,865 (11,363) 95,677 Total $ 214,893 $ 86,787 $ (37,365) $ 264,315 Deferred contract costs are recorded within Deferred contract costs and Long-term deferred contract costs on the Unaudited Consolidated Balance Sheets. Amortization of deferred contract costs is recorded in Cost of revenues, Sales and marketing, and General and administrative in the Unaudited Consolidated Statements of Operations and Comprehensive Income. Remaining Performance Obligations The balance of the Company’s remaining performance obligations related to minimum monthly fees on its term-based contracts was approximately $49,698 as of March 31, 2022, which will be generally recognized over the next 24 months. This balance excludes the value of unsatisfied performance obligations for contracts that have an original expected duration of one year or less and contracts for which the variable consideration is allocated entirely to wholly unsatisfied performance obligations. |
Business Combinations
Business Combinations | 9 Months Ended |
Mar. 31, 2022 | |
Business Combinations [Abstract] | |
Business Combinations | 4) Business Combinations On August 31, 2021, the Company entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Blue Marble Payroll, LLC (“Blue Marble”) and its equity holders and acquired all of the issued and outstanding equity interests of Blue Marble for cash consideration of $60,961, subject to customary purchase price adjustments. Blue Marble’s payroll platform enables U.S.-based companies to manage payroll for employees outside the U.S. in line with complex local and country-specific requirements across many countries. This acquisition enables the Company to better serve its clients in managing their international workforces through a unified solution to pay employees, automate processes and stay compliant with regulations in other countries. An entity affiliated with Steven I. Sarowitz, the Chairman of the board of directors and the largest shareholder of the Company, was the largest equity holder of Blue Marble. The board of directors of the Company appointed the Audit Committee, which is comprised solely of directors who are independent of the management of Blue Marble, the Blue Marble equity holders and the Company, to evaluate, assess and negotiate on its behalf the terms and conditions in the Purchase Agreement. The Audit Committee and the disinterested directors of the Company’s board of directors unanimously approved the Purchase Agreement and transactions specified within it. The preliminary allocation of the purchase price for Blue Marble is as follows: August 31, 2021 Proprietary technology $ 21,200 Client relationships 3,000 Trade names 1,200 Goodwill 34,776 Other assets acquired 2,659 Liabilities assumed (1,874) Total purchase price $ 60,961 On January 18, 2022, the Company acquired all of the shares outstanding of Cloudsnap, Inc., ("Cloudsnap") through a merger for cash consideration of $50,002, which was paid upon closing. Cloudsnap is a provider of a flexible, low-code solution for integrating disparate business applications. This transaction enables the Company to deliver modern integrations and seamless data sharing between critical systems more efficiently and effectively, while helping to unify and automate business processes across clients' HR, finance, benefits, and other systems. The preliminary allocation of the purchase price for Cloudsnap is as follows: January 18, 2022 Proprietary technology $ 15,800 Goodwill 33,757 Other assets acquired 3,041 Liabilities assumed (2,596) Total purchase price $ 50,002 The Company accounts for business combinations in accordance with ASC 805, Business Combinations. The Company applied the acquisition method of accounting and recorded the assets acquired and liabilities assumed at their respective estimated fair values as of the dates of the acquisitions with the excess consideration paid recorded as goodwill. The fair values of assets acquired and liabilities assumed are currently provisional and are subject to change over the measurement periods as the Company continues to evaluate and analyze the estimates and assumptions used in the valuation. The measurement periods will end no later than one year from the respective acquisition dates. The results from these acquisitions have been included in the Company’s consolidated financial statements since the closing of the acquisitions and are not material to the Company. Pro forma information is not presented because the effects of the acquisitions are not material to the Company’s consolidated financial statements. The goodwill related to these transactions is primarily attributable to the assembled workforce and growth opportunities from the expansion and enhancement of the Company’s product offerings. The goodwill associated with the Blue Marble acquisition is deductible for income tax purposes. The goodwill associated with the Cloudsnap acquisition is not deductible for income tax purposes. Direct costs related to the acquisitions were immaterial and were expensed as incurred as General and administrative in the Unaudited Consolidated Statements of Operations and Comprehensive Income. |
Balance Sheet Information
Balance Sheet Information | 9 Months Ended |
Mar. 31, 2022 | |
Balance Sheet Related Disclosures [Abstract] | |
Balance Sheet Information | (5) Balance Sheet Information The following tables provide details of selected consolidated balance sheet items: Activity in the allowance for credit losses related to accounts receivable was as follows: Balance at June 30, 2021 $ 800 Charged to expense 238 Write-offs (183) Balance at March 31, 2022 $ 855 Capitalized internal-use software and accumulated amortization were as follows: June 30, March 31, Capitalized internal-use software $ 150,922 $ 182,140 Accumulated amortization (105,904) (124,427) Capitalized internal-use software, net $ 45,018 $ 57,713 Amortization of capitalized internal-use software costs is included in Cost of revenues and amounted to $6,005 and $6,308 for the three months ended March 31, 2021 and 2022, respectively, and $17,273 and $18,523 for the nine months ended March 31, 2021 and 2022, respectively. Property and equipment, net consist of the following: June 30, March 31, Office equipment $ 5,211 $ 4,365 Computer equipment 45,420 54,172 Furniture and fixtures 13,104 12,791 Software 6,641 8,278 Leasehold improvements 46,814 47,255 Time clocks rented by clients 5,399 6,423 Total 122,589 133,284 Accumulated depreciation (62,754) (69,280) Property and equipment, net $ 59,835 $ 64,004 Depreciation expense amounted to $3,966 and $4,098 for the three months ended March 31, 2021 and 2022, respectively, and $11,985 and $11,914 for the nine months ended March 31, 2021 and 2022, respectively. The following table summarizes changes in goodwill during the nine months ended March 31, 2022: March 31, Balance at June 30, 2021 $ 33,650 Additions attributable to acquisitions 68,533 Balance at March 31, 2022 $ 102,183 Refer to Note 4 for further details on current year acquisitions. The Company’s amortizable intangible assets and estimated useful lives are as follows: June 30, March 31, Weighted Proprietary technology $ 6,129 $ 43,129 6.0 Client relationships 19,200 22,200 7.8 Non-solicitation agreements 1,600 1,600 3.1 Trade names 440 1,640 5.0 Total 27,369 68,569 Accumulated amortization (14,342) (20,324) Intangible assets, net $ 13,027 $ 48,245 Amortization expense for acquired intangible assets was $1,028 and $2,630 for the three months ended March 31, 2021 and 2022, respectively, and $2,812 and $5,982 for the nine months ended March 31, 2021 and 2022, respectively. Future amortization expense for acquired intangible assets as of March 31, 2022 is as follows: Remainder of fiscal 2022 $ 2,770 Fiscal 2023 10,948 Fiscal 2024 9,943 Fiscal 2025 8,888 Fiscal 2026 7,269 Thereafter 8,427 Total $ 48,245 The components of accrued expenses were as follows: June 30, March 31, Accrued payroll and personnel costs $ 73,969 $ 67,965 Operating lease liabilities 7,549 8,270 Deferred revenue 9,442 14,326 Other 12,149 18,259 Total accrued expenses $ 103,109 $ 108,820 |
Corporate Investments and Funds
Corporate Investments and Funds Held for Clients | 9 Months Ended |
Mar. 31, 2022 | |
Corporate Investments and Funds Held for Clients [Abstract] | |
Corporate Investments and Funds Held for Clients | (6) Corporate Investments and Funds Held for Clients Corporate investments and funds held for clients consist of the following: June 30, 2021 Type of Issue Amortized Gross Gross Fair value Cash and cash equivalents $ 202,287 $ — $ — $ 202,287 Funds held for clients' cash and cash equivalents 1,743,594 — — 1,743,594 Available-for-sale securities: Corporate bonds 13,390 70 — 13,460 Asset-backed securities 7,062 17 — 7,079 Total available-for-sale securities (1) 20,452 87 — 20,539 Total investments $ 1,966,333 $ 87 $ — $ 1,966,420 (1) Included within the fair value of total available-for-sale securities above is $4,456 of corporate investments and $16,083 of funds held for clients. March 31, 2022 Type of Issue Amortized Gross Gross Fair value Cash and cash equivalents $ 96,465 $ — $ — $ 96,465 Funds held for clients' cash and cash equivalents 4,176,903 — — 4,176,903 Available-for-sale securities: Commercial paper 49,440 — (113) 49,327 Corporate bonds 54,607 1 (1,289) 53,319 Asset-backed securities 8,082 — (135) 7,947 Certificates of deposit 23,785 — (50) 23,735 U.S treasury securities 4,036 — (90) 3,946 U.S government agency securities 7,000 — (372) 6,628 Other 2,823 — (61) 2,762 Total available-for-sale securities (2) 149,773 1 (2,110) 147,664 Total investments $ 4,423,141 $ 1 $ (2,110) $ 4,421,032 (2) All available-for-sale securities are included in funds held for clients. Cash and cash equivalents and funds held for clients’ cash and cash equivalents include demand deposit accounts and money market funds at June 30, 2021 and March 31, 2022. Classification of investments on the unaudited consolidated balance sheets is as follows: June 30, 2021 March 31, 2022 Cash and cash equivalents $ 202,287 $ 96,465 Corporate investments 4,456 — Funds held for clients 1,759,677 4,324,567 Total investments $ 1,966,420 $ 4,421,032 Available-for-sale securities that have been in an unrealized loss position for a period of less than 12 months as of March 31, 2022 had fair market value as follows: March 31, 2022 Securities in an unrealized loss Gross Fair Commercial paper $ (113) $ 49,327 Corporate bonds (1,289) 51,909 Asset-backed securities (135) 7,826 Certificates of deposit (50) 22,734 U.S. treasury securities (90) 3,946 U.S. government agency securities (372) 6,628 Other (61) 2,762 Total available-for-sale securities $ (2,110) $ 145,132 There were no available-for-sale securities in an unrealized loss position at June 30, 2021. As a result, no securities have been in an unrealized loss position for more than 12 months as of March 31, 2022. The Company regularly reviews the composition of its portfolio to determine the existence of credit impairment. The Company did not recognize any credit impairment losses during the three or nine months ended March 31, 2021 or 2022. All securities in the Company’s portfolio held an A-1 rating or better as of March 31, 2022. The Company did not make any material reclassification adjustments out of accumulated other comprehensive income for realized gains and losses on the sale of available-for-sale securities during the three or nine months ended March 31, 2021 or 2022. There were no realized gains or losses on the sale of available-for-sale securities for the three or nine months ended March 31, 2021 or 2022. Expected maturities of available-for-sale securities at March 31, 2022 are as follows: Amortized Fair One year or less $ 98,775 $ 98,392 One year to two years 26,988 26,369 Two years to three years 20,000 19,138 Three years to five years 4,010 3,765 Total available-for-sale securities $ 149,773 $ 147,664 |
Fair Value Measurement
Fair Value Measurement | 9 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurement | (7) Fair Value Measurement Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: • Level 1—Quoted prices in active markets for identical assets and liabilities. • Level 2—Quoted prices in active markets for similar assets and liabilities, or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. • Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs. The Company measures certain cash and cash equivalents, accounts receivable, accounts payable and client fund obligations at fair value on a recurring basis using Level 1 inputs. The Company considers the recorded value of these financial assets and liabilities to approximate the fair value of the respective assets and liabilities at June 30, 2021 and March 31, 2022 based upon the short-term nature of these assets and liabilities. Marketable securities, consisting of securities classified as available-for-sale as well as certain cash equivalents, are recorded at fair value on a recurring basis using Level 2 inputs obtained from an independent pricing service. Available-for-sale securities include commercial paper, corporate bonds, asset-backed securities, certificate of deposit, U.S. treasury securities, U.S. government agency and other securities. The independent pricing service utilizes a variety of inputs including benchmark yields, broker/dealer quoted prices, reported trades, issuer spreads as well as other available market data. The Company, on a sample basis, validates the pricing from the independent pricing service against another third-party pricing source for reasonableness. The Company has not adjusted any prices obtained by the independent pricing service, as it believes they are appropriately valued. There were no available-for-sale securities classified in Level 3 of the fair value hierarchy at June 30, 2021 or March 31, 2022. The fair value level for the Company’s cash and cash equivalents and available-for-sale securities is as follows: June 30, 2021 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 202,287 $ 202,287 $ — $ — Funds held for clients' cash and cash equivalents 1,743,594 1,743,594 — — Available-for-sale securities: Corporate bonds 13,460 — 13,460 — Asset-backed securities 7,079 — 7,079 — Total available-for-sale securities 20,539 — 20,539 — Total investments $ 1,966,420 $ 1,945,881 $ 20,539 $ — March 31, 2022 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 96,465 $ 96,465 $ — $ — Funds held for clients' cash and cash equivalents 4,176,903 4,176,903 — — Available-for-sale securities: Commercial paper 49,327 — 49,327 — Corporate bonds 53,319 — 53,319 — Asset-backed securities 7,947 — 7,947 — Certificates of deposit 23,735 — 23,735 — U.S. treasury securities 3,946 — 3,946 — U.S government agency securities 6,628 — 6,628 — Other 2,762 — 2,762 — Total available-for-sale securities 147,664 — 147,664 — Total investments $ 4,421,032 $ 4,273,368 $ 147,664 $ — |
Debt
Debt | 9 Months Ended |
Mar. 31, 2022 | |
Debt Disclosure [Abstract] | |
Debt | (8) Debt In July 2019, the Company entered into a five The proceeds of any borrowings are to be used to fund working capital, capital expenditures and general corporate purposes, including permitted acquisitions, permitted investments, permitted distributions and share repurchases. The Company may generally borrow, prepay and reborrow under the credit facility and terminate or reduce the lenders’ commitments at any time prior to revolving credit facility expiration without a premium or a penalty, other than customary “breakage” costs with respect to London Interbank Offered Rate (“LIBOR”) revolving loans. Any borrowings under the credit facility will generally bear interest, at the Company’s option, at a rate per annum determined by reference to either the LIBOR (or a replacement index for the LIBOR rate) or an adjusted base rate, in each case plus an applicable margin ranging from 0.875% to 1.375% and 0.0% to 0.375%, respectively, based on the then-applicable net senior secured leverage ratio. Additionally, the Company is required to pay certain commitment, letter of credit fronting and letter of credit participation fees on available and/or undrawn portions of the credit facility. Under the credit facility, the Company is required to comply with certain customary affirmative and negative covenants, including a requirement to maintain a maximum net total leverage ratio of not greater than 4.00 to 1.00, a maximum net senior secured leverage ratio of not greater than 3.50 to 1.00 and a minimum interest coverage ratio of not less than 3.00 to 1.00. As of March 31, 2022, the Company was in compliance with all of the aforementioned covenants. |
Stock-Based Compensation
Stock-Based Compensation | 9 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Stock-Based Compensation | (9) Stock-Based Compensation The Company maintains a 2008 Equity Incentive Plan (the “2008 Plan”) and a 2014 Equity Incentive Plan (the “2014 Plan”) pursuant to which the Company has reserved shares of its common stock for issuance to its employees, directors and non-employee third parties. The 2014 Plan serves as the successor to the 2008 Plan and permits the granting of restricted stock units and other equity incentives at the discretion of the compensation committee of the Company’s board of directors. No new awards have been or will be issued under the 2008 Plan since the effective date of the 2014 Plan. Outstanding awards under the 2008 Plan continue to be subject to the terms and conditions of the 2008 Plan. The number of shares of common stock reserved for issuance under the 2014 Plan may increase each calendar year, continuing through and including January 1, 2024. The number of shares added each year may be equal to the lesser of (a) four and five tenths percent (4.5%) of the number of shares of common stock of the Company issued and outstanding on the immediately preceding December 31, or (b) an amount determined by the Company’s board of directors. The Company's board of directors approved the increase in the number of common shares in reserve for issuance under the 2014 Plan by 2,400 shares, effective January 1, 2022. As of March 31, 2022, the Company had 14,391 shares allocated to the plans, of which 1,999 shares were subject to outstanding options or awards. Generally, the Company issues previously unissued shares for the exercise of stock options or vesting of awards; however, shares previously subject to 2014 Plan grants or awards that are forfeited or net settled at exercise or release may be reissued to satisfy future issuances. The following table summarizes changes in the number of shares available for grant under the Company’s equity incentive plans during the nine months ended March 31, 2022: Number of Available for grant at July 1, 2021 10,312 January 1, 2022 Evergreen provision increase 2,400 RSUs granted (614) MSUs granted (47) Shares withheld in settlement of taxes and/or exercise price 280 Forfeitures 120 Shares removed (59) Available for grant at March 31, 2022 12,392 Shares removed represents forfeitures of shares and shares withheld in settlement of taxes and/or payment of exercise price related to grants made under the 2008 Plan. As noted above, no new awards will be issued under the 2008 Plan. Stock-based compensation expense related to restricted stock units (“RSUs”), market share units (“MSUs”) and the Employee Stock Purchase Plan is included in the following line items in the accompanying unaudited consolidated statements of operations and comprehensive income: Three Months Ended March 31, Nine Months Ended March 31, 2021 2022 2021 2022 Cost of revenues $ 1,972 $ 2,936 $ 5,773 $ 8,860 Sales and marketing 3,938 5,119 11,783 15,994 Research and development 2,602 4,855 7,570 13,963 General and administrative 7,499 11,485 21,821 31,380 Total stock-based compensation expense $ 16,011 $ 24,395 $ 46,947 $ 70,197 In addition, the Company capitalized $652 and $1,886 of stock-based compensation expense in its capitalized internal-use software costs in the three months ended March 31, 2021 and 2022, respectively, and $1,949 and $5,312 during the nine months ended March 31, 2021 and 2022, respectively. In August 2020, the compensation committee of the Company’s board of directors approved the modification of the performance targets for vesting of the performance-based restricted stock units granted in fiscal 2020. The Company recorded $1,776 and $1,819 in stock-based compensation expense during the three months ended March 31, 2021 and 2022, respectively, and $4,560 and $4,877 during the nine months ended March 31, 2021 and 2022, respectively, related to these modified performance-based restricted stock units. In March 2022, Michael Haske announced his intent to resign from his position effective September 1, 2022. In connection with his resignation, the Company’s board of directors approved a Transition and Separation Agreement and a Consulting Services Agreement whereby Mr. Haske will provide consulting services to the Company for a period of one year after the end of his employment on September 1, 2022. Pursuant to these agreements, the compensation committee of the Company's board of directors approved the modifications of certain of Mr. Haske's outstanding RSUs and MSUs to allow the awards to continue to vest after the end of his service period. As a result, the Company will record the cumulative effect of the modifications and accelerate the recognition of the remaining expense associated with certain of Mr. Haske's unmodified outstanding awards over his remaining substantive service period. The modifications of these awards did not have a material impact on the Company's financial statements. There were no stock options granted during the nine months ended March 31, 2022. The table below presents stock option activity during the nine months ended March 31, 2022: Outstanding Options Number of Weighted Weighted Aggregate Balance at July 1, 2021 765 $ 16.06 2.4 $ 133,550 Options exercised (204) $ 9.69 Balance at March 31, 2022 561 $ 18.37 1.8 $ 105,094 Options vested and exercisable at March 31, 2022 561 $ 18.37 1.8 $ 105,094 The total intrinsic value of options exercised was $20,975 and $1,819 during the three months ended March 31, 2021 and 2022, respectively, and $58,252 and $49,446 during the nine months ended March 31, 2021 and 2022, respectively. The Company grants RSUs under the 2014 Plan with terms determined at the discretion of the compensation committee of the Company’s board of directors. RSUs generally vest over three The following table represents restricted stock unit activity during the nine months ended March 31, 2022: Units Weighted RSU balance at July 1, 2021 1,388 $ 100.33 RSUs granted 614 $ 247.98 RSUs vested (549) $ 84.83 RSUs forfeited (115) $ 160.61 RSU balance at March 31, 2022 1,338 $ 169.40 At March 31, 2022, there was $113,191 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested restricted stock units granted. That cost is expected to be recognized over a weighted average period of 1.9 years. The Company also grants MSUs under the 2014 Plan with terms determined at the discretion of the Committee. The actual number of MSUs that will be eligible to vest is based on the achievement of a relative total shareholder return (“TSR”) target as compared to the TSR realized by each of the companies comprising the Russell 3000 Index over an approximately three The following table represents market share unit activity during the nine months ended March 31, 2022: Units Weighted MSU balance at July 1, 2021 58 $ 178.04 MSUs granted 48 $ 361.02 MSUs forfeited (5) $ 178.04 MSU balance at March 31, 2022 101 $ 263.83 The Company estimated the grant date fair value of the MSUs using a Monte Carlo simulation model that included the following assumptions: Nine Months Ended 2021 2022 Valuation assumptions: Expected dividend yield —% —% Expected volatility 52.0 % 47.4 - 47.5% Expected term (years) 3.04 2.92 - 3.04 Risk‑free interest rate 0.18% 0.43 - 0.47% At March 31, 2022, there was $16,131 of total unrecognized compensation cost, net of estimated forfeitures, related to unvested MSUs. That cost is expected to be recognized over a period of 2.2 years. |
Litigation
Litigation | 9 Months Ended |
Mar. 31, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Litigation | (10) Litigation On November 16, 2020, a potential class action complaint was filed against the Company with the Circuit Court of Cook County alleging that the Company violated the Illinois Biometric Information Privacy Act. The complaint seeks statutory damages, attorney’s fees and other costs. The Company is unable to estimate any reasonably possible loss, or range of loss, with respect to this matter at this time. The Company intends to vigorously defend against this lawsuit. From time to time, the Company is subject to litigation arising in the ordinary course of business. Many of these matters are covered in whole or in part by insurance. In the opinion of the Company’s management, the ultimate |
Income Taxes
Income Taxes | 9 Months Ended |
Mar. 31, 2022 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | (11) Income Taxes The Company’s quarterly provision for income taxes is based on the annual effective rate method. The Company’s quarterly provision for income taxes also includes the tax impact of certain unusual or infrequently occurring items, if any, including changes in judgment about valuation allowances and effects of changes in tax laws or rates, and other discrete items in the interim period in which they occur. The Company’s effective tax rate was 5.4% and 26.0% for the three months ended March 31, 2021 and 2022, respectively. The Company’s effective tax rate for the three months ended March 31, 2021 was lower than the federal statutory rate of 21% primarily due to excess tax benefits from employee stock-based compensation and state and local income taxes, partially offset by an increase to the valuation allowance. The Company's effective tax rate for the three months ended March 31, 2022 was higher than the federal statutory rate of 21% primarily due to an increase in non-deductible stock-based compensation under Internal Revenue Code Section 162(m), partially offset by research and development tax credits. The Company's effective tax rate was (22.5)% and (16.4)% for the nine months ended March 31, 2021 and 2022, respectively. The Company's effective tax rate for the nine months ended March 31, 2021, and March 31, 2022 was lower than the federal statutory rate of 21% primarily due to excess tax benefits from employee stock-based compensation, research and development tax credits and state and local income taxes. |
Net Income Per Share
Net Income Per Share | 9 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Net Income Per Share | (12) Net Income Per Share Basic net income per common share is computed using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted-average number of common shares outstanding during the period and, if dilutive, potential common shares outstanding during the period. The Company’s potential common shares consist of the incremental common shares issuable upon the exercise of stock options, the release of restricted stock units and market share units, and the shares purchasable via the employee stock purchase plan as of the balance sheet date. The following table presents the calculation of basic and diluted net income per share: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Numerator: Net income $ 36,834 $ 34,846 $ 58,936 $ 75,631 Denominator: Weighted-average shares used in computing net income per share: Basic 54,415 55,114 54,244 54,996 Weighted-average effect of potentially dilutive shares: Employee stock options, restricted stock units, market share units and employee stock purchase plan shares 1,999 1,253 2,094 1,441 Diluted 56,414 56,367 56,338 56,437 Net income per share: Basic $ 0.68 $ 0.63 $ 1.09 $ 1.38 Diluted $ 0.65 $ 0.62 $ 1.05 $ 1.34 The following table summarizes the outstanding restricted stock units and market share units that were excluded from the diluted per share calculation for the periods presented because to include them would have been antidilutive: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Market share units — 19 — 19 Restricted stock units 1 62 13 59 Total 1 81 13 78 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Mar. 31, 2022 | |
Accounting Policies [Abstract] | |
Basis of Presentation, Consolidation and Use of Estimates | (a) Basis of Presentation, Consolidation and Use of Estimates These unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. |
Interim Unaudited Consolidated Financial Information | (b) Interim Unaudited Consolidated Financial Information |
Income Taxes | (c) Income Taxes Income taxes are accounted for in accordance with ASC 740, Income Taxes, using the asset and liability method. The Company’s provision for income taxes is based on the annual effective rate method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. |
Recently Issued Accounting Standards | (d) Recently Issued Accounting Standards |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Mar. 31, 2022 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of disaggregation of revenue | The following table disaggregates revenue by Recurring fees and Implementation services and other, which the Company believes depicts the nature, amount and timing of its revenue: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Recurring fees $ 178,711 $ 236,657 $ 448,864 $ 599,513 Implementation services and other 6,216 8,305 16,331 21,314 Total revenues from contracts $ 184,927 $ 244,962 $ 465,195 $ 620,827 |
Schedule of changes in deferred revenue related to nonrefundable upfront fees | The following table summarizes the changes in deferred revenue (i.e., contract liability) related to these nonrefundable upfront fees as follows: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Balance at beginning of the period $ 7,065 $ 9,341 $ 8,434 $ 8,734 Deferral of revenue 5,821 9,105 11,811 18,865 Revenue recognized (4,097) (6,044) (11,456) (15,197) Balance at end of the period $ 8,789 $ 12,402 $ 8,789 $ 12,402 |
Schedule of deferred contract costs and the related amortization expense | The following tables present the deferred contract costs and the related amortization expense for these deferred contract costs: Three Months Ended March 31, 2021 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 125,817 $ 17,315 $ (7,390) $ 135,742 Costs to fulfill a contract 55,657 8,872 (2,607) 61,922 Total $ 181,474 $ 26,187 $ (9,997) $ 197,664 Three Months Ended March 31, 2022 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 155,564 $ 22,256 $ (9,182) $ 168,638 Costs to fulfill a contract 86,115 13,825 (4,263) 95,677 Total $ 241,679 $ 36,081 $ (13,445) $ 264,315 Nine Months Ended March 31, 2021 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 113,575 $ 43,026 $ (20,859) $ 135,742 Costs to fulfill a contract 44,468 24,376 (6,922) 61,922 Total $ 158,043 $ 67,402 $ (27,781) $ 197,664 Nine Months Ended March 31, 2022 Beginning Capitalized Amortization Ending Costs to obtain a new contract $ 145,718 $ 48,922 $ (26,002) $ 168,638 Costs to fulfill a contract 69,175 37,865 (11,363) 95,677 Total $ 214,893 $ 86,787 $ (37,365) $ 264,315 |
Business Combinations (Tables)
Business Combinations (Tables) | 9 Months Ended |
Mar. 31, 2022 | |
Business Combinations [Abstract] | |
Summaries of the preliminary allocations of purchase prices | The preliminary allocation of the purchase price for Blue Marble is as follows: August 31, 2021 Proprietary technology $ 21,200 Client relationships 3,000 Trade names 1,200 Goodwill 34,776 Other assets acquired 2,659 Liabilities assumed (1,874) Total purchase price $ 60,961 The preliminary allocation of the purchase price for Cloudsnap is as follows: January 18, 2022 Proprietary technology $ 15,800 Goodwill 33,757 Other assets acquired 3,041 Liabilities assumed (2,596) Total purchase price $ 50,002 |
Balance Sheet Information (Tabl
Balance Sheet Information (Tables) | 9 Months Ended |
Mar. 31, 2022 | |
Balance Sheet Related Disclosures [Abstract] | |
Schedule of activity in the allowance for credit losses related to accounts receivable | Activity in the allowance for credit losses related to accounts receivable was as follows: Balance at June 30, 2021 $ 800 Charged to expense 238 Write-offs (183) Balance at March 31, 2022 $ 855 |
Schedule of capitalized internal-use software and accumulated amortization | Capitalized internal-use software and accumulated amortization were as follows: June 30, March 31, Capitalized internal-use software $ 150,922 $ 182,140 Accumulated amortization (105,904) (124,427) Capitalized internal-use software, net $ 45,018 $ 57,713 |
Schedule of property and equipment, net | Property and equipment, net consist of the following: June 30, March 31, Office equipment $ 5,211 $ 4,365 Computer equipment 45,420 54,172 Furniture and fixtures 13,104 12,791 Software 6,641 8,278 Leasehold improvements 46,814 47,255 Time clocks rented by clients 5,399 6,423 Total 122,589 133,284 Accumulated depreciation (62,754) (69,280) Property and equipment, net $ 59,835 $ 64,004 |
Schedule of changes in goodwill | The following table summarizes changes in goodwill during the nine months ended March 31, 2022: March 31, Balance at June 30, 2021 $ 33,650 Additions attributable to acquisitions 68,533 Balance at March 31, 2022 $ 102,183 |
Schedule of amortizable intangible assets and estimated useful lives | The Company’s amortizable intangible assets and estimated useful lives are as follows: June 30, March 31, Weighted Proprietary technology $ 6,129 $ 43,129 6.0 Client relationships 19,200 22,200 7.8 Non-solicitation agreements 1,600 1,600 3.1 Trade names 440 1,640 5.0 Total 27,369 68,569 Accumulated amortization (14,342) (20,324) Intangible assets, net $ 13,027 $ 48,245 |
Schedule of future amortization expense for acquired intangible assets | Future amortization expense for acquired intangible assets as of March 31, 2022 is as follows: Remainder of fiscal 2022 $ 2,770 Fiscal 2023 10,948 Fiscal 2024 9,943 Fiscal 2025 8,888 Fiscal 2026 7,269 Thereafter 8,427 Total $ 48,245 |
Schedule of components of accrued expenses | The components of accrued expenses were as follows: June 30, March 31, Accrued payroll and personnel costs $ 73,969 $ 67,965 Operating lease liabilities 7,549 8,270 Deferred revenue 9,442 14,326 Other 12,149 18,259 Total accrued expenses $ 103,109 $ 108,820 |
Corporate Investments and Fun_2
Corporate Investments and Funds Held For Clients (Tables) | 9 Months Ended |
Mar. 31, 2022 | |
Corporate Investments and Funds Held for Clients [Abstract] | |
Schedule of corporate investments and funds held for clients | Corporate investments and funds held for clients consist of the following: June 30, 2021 Type of Issue Amortized Gross Gross Fair value Cash and cash equivalents $ 202,287 $ — $ — $ 202,287 Funds held for clients' cash and cash equivalents 1,743,594 — — 1,743,594 Available-for-sale securities: Corporate bonds 13,390 70 — 13,460 Asset-backed securities 7,062 17 — 7,079 Total available-for-sale securities (1) 20,452 87 — 20,539 Total investments $ 1,966,333 $ 87 $ — $ 1,966,420 (1) Included within the fair value of total available-for-sale securities above is $4,456 of corporate investments and $16,083 of funds held for clients. March 31, 2022 Type of Issue Amortized Gross Gross Fair value Cash and cash equivalents $ 96,465 $ — $ — $ 96,465 Funds held for clients' cash and cash equivalents 4,176,903 — — 4,176,903 Available-for-sale securities: Commercial paper 49,440 — (113) 49,327 Corporate bonds 54,607 1 (1,289) 53,319 Asset-backed securities 8,082 — (135) 7,947 Certificates of deposit 23,785 — (50) 23,735 U.S treasury securities 4,036 — (90) 3,946 U.S government agency securities 7,000 — (372) 6,628 Other 2,823 — (61) 2,762 Total available-for-sale securities (2) 149,773 1 (2,110) 147,664 Total investments $ 4,423,141 $ 1 $ (2,110) $ 4,421,032 (2) All available-for-sale securities are included in funds held for clients. |
Schedule of the classification of investments | Classification of investments on the unaudited consolidated balance sheets is as follows: June 30, 2021 March 31, 2022 Cash and cash equivalents $ 202,287 $ 96,465 Corporate investments 4,456 — Funds held for clients 1,759,677 4,324,567 Total investments $ 1,966,420 $ 4,421,032 |
Schedule of available-for-sale securities that have been in an unrealized loss position for less than 12 months | Available-for-sale securities that have been in an unrealized loss position for a period of less than 12 months as of March 31, 2022 had fair market value as follows: March 31, 2022 Securities in an unrealized loss Gross Fair Commercial paper $ (113) $ 49,327 Corporate bonds (1,289) 51,909 Asset-backed securities (135) 7,826 Certificates of deposit (50) 22,734 U.S. treasury securities (90) 3,946 U.S. government agency securities (372) 6,628 Other (61) 2,762 Total available-for-sale securities $ (2,110) $ 145,132 |
Schedule of expected maturities of available-for-sale securities | Expected maturities of available-for-sale securities at March 31, 2022 are as follows: Amortized Fair One year or less $ 98,775 $ 98,392 One year to two years 26,988 26,369 Two years to three years 20,000 19,138 Three years to five years 4,010 3,765 Total available-for-sale securities $ 149,773 $ 147,664 |
Fair Value Measurement (Tables)
Fair Value Measurement (Tables) | 9 Months Ended |
Mar. 31, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of fair value level for cash and cash equivalents and available-for-sale securities measured on a recurring basis | The fair value level for the Company’s cash and cash equivalents and available-for-sale securities is as follows: June 30, 2021 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 202,287 $ 202,287 $ — $ — Funds held for clients' cash and cash equivalents 1,743,594 1,743,594 — — Available-for-sale securities: Corporate bonds 13,460 — 13,460 — Asset-backed securities 7,079 — 7,079 — Total available-for-sale securities 20,539 — 20,539 — Total investments $ 1,966,420 $ 1,945,881 $ 20,539 $ — March 31, 2022 Total Level 1 Level 2 Level 3 Cash and cash equivalents $ 96,465 $ 96,465 $ — $ — Funds held for clients' cash and cash equivalents 4,176,903 4,176,903 — — Available-for-sale securities: Commercial paper 49,327 — 49,327 — Corporate bonds 53,319 — 53,319 — Asset-backed securities 7,947 — 7,947 — Certificates of deposit 23,735 — 23,735 — U.S. treasury securities 3,946 — 3,946 — U.S government agency securities 6,628 — 6,628 — Other 2,762 — 2,762 — Total available-for-sale securities 147,664 — 147,664 — Total investments $ 4,421,032 $ 4,273,368 $ 147,664 $ — |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 9 Months Ended |
Mar. 31, 2022 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of changes in the number of shares available for grant under equity incentive plans | The following table summarizes changes in the number of shares available for grant under the Company’s equity incentive plans during the nine months ended March 31, 2022: Number of Available for grant at July 1, 2021 10,312 January 1, 2022 Evergreen provision increase 2,400 RSUs granted (614) MSUs granted (47) Shares withheld in settlement of taxes and/or exercise price 280 Forfeitures 120 Shares removed (59) Available for grant at March 31, 2022 12,392 |
Schedule of stock-based compensation expense related to restricted stock units, market share units and the Employee Stock Purchase Plan | Stock-based compensation expense related to restricted stock units (“RSUs”), market share units (“MSUs”) and the Employee Stock Purchase Plan is included in the following line items in the accompanying unaudited consolidated statements of operations and comprehensive income: Three Months Ended March 31, Nine Months Ended March 31, 2021 2022 2021 2022 Cost of revenues $ 1,972 $ 2,936 $ 5,773 $ 8,860 Sales and marketing 3,938 5,119 11,783 15,994 Research and development 2,602 4,855 7,570 13,963 General and administrative 7,499 11,485 21,821 31,380 Total stock-based compensation expense $ 16,011 $ 24,395 $ 46,947 $ 70,197 |
Schedule of stock option activity | The table below presents stock option activity during the nine months ended March 31, 2022: Outstanding Options Number of Weighted Weighted Aggregate Balance at July 1, 2021 765 $ 16.06 2.4 $ 133,550 Options exercised (204) $ 9.69 Balance at March 31, 2022 561 $ 18.37 1.8 $ 105,094 Options vested and exercisable at March 31, 2022 561 $ 18.37 1.8 $ 105,094 |
Schedule of restricted stock unit activity | The following table represents restricted stock unit activity during the nine months ended March 31, 2022: Units Weighted RSU balance at July 1, 2021 1,388 $ 100.33 RSUs granted 614 $ 247.98 RSUs vested (549) $ 84.83 RSUs forfeited (115) $ 160.61 RSU balance at March 31, 2022 1,338 $ 169.40 |
Schedule of market share unit activity | The following table represents market share unit activity during the nine months ended March 31, 2022: Units Weighted MSU balance at July 1, 2021 58 $ 178.04 MSUs granted 48 $ 361.02 MSUs forfeited (5) $ 178.04 MSU balance at March 31, 2022 101 $ 263.83 |
Summary of the assumptions used for estimating the grant date fair value of MSUs | The Company estimated the grant date fair value of the MSUs using a Monte Carlo simulation model that included the following assumptions: Nine Months Ended 2021 2022 Valuation assumptions: Expected dividend yield —% —% Expected volatility 52.0 % 47.4 - 47.5% Expected term (years) 3.04 2.92 - 3.04 Risk‑free interest rate 0.18% 0.43 - 0.47% |
Net Income Per Share (Tables)
Net Income Per Share (Tables) | 9 Months Ended |
Mar. 31, 2022 | |
Earnings Per Share [Abstract] | |
Schedule of calculation of basic and diluted net income per share | The following table presents the calculation of basic and diluted net income per share: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Numerator: Net income $ 36,834 $ 34,846 $ 58,936 $ 75,631 Denominator: Weighted-average shares used in computing net income per share: Basic 54,415 55,114 54,244 54,996 Weighted-average effect of potentially dilutive shares: Employee stock options, restricted stock units, market share units and employee stock purchase plan shares 1,999 1,253 2,094 1,441 Diluted 56,414 56,367 56,338 56,437 Net income per share: Basic $ 0.68 $ 0.63 $ 1.09 $ 1.38 Diluted $ 0.65 $ 0.62 $ 1.05 $ 1.34 |
Summary of anti-dilutive securities | The following table summarizes the outstanding restricted stock units and market share units that were excluded from the diluted per share calculation for the periods presented because to include them would have been antidilutive: Three Months Ended Nine Months Ended 2021 2022 2021 2022 Market share units — 19 — 19 Restricted stock units 1 62 13 59 Total 1 81 13 78 |
Revenue - Disaggregation (Detai
Revenue - Disaggregation (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Revenue | ||||
Period of term arrangements not cancellable by client | 2 years | |||
Disaggregation of revenue | ||||
Total revenues from contracts | $ 244,962 | $ 184,927 | $ 620,827 | $ 465,195 |
Maximum | ||||
Revenue | ||||
Period of notice to cancel by client | 60 days | |||
Recurring fees | ||||
Disaggregation of revenue | ||||
Total revenues from contracts | 236,657 | 178,711 | $ 599,513 | 448,864 |
Implementation services and other | ||||
Disaggregation of revenue | ||||
Total revenues from contracts | $ 8,305 | $ 6,216 | $ 21,314 | $ 16,331 |
Revenue - Deferred Revenue (Det
Revenue - Deferred Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Changes in deferred revenue related to nonrefundable upfront fees | ||||
Beginning balance | $ 9,341 | $ 7,065 | $ 8,734 | $ 8,434 |
Deferral of revenue | 9,105 | 5,821 | 18,865 | 11,811 |
Revenue recognized | (6,044) | (4,097) | (15,197) | (11,456) |
Ending balance | 12,402 | $ 8,789 | 12,402 | $ 8,789 |
Implementation services and other | ||||
Changes in deferred revenue related to nonrefundable upfront fees | ||||
Deferred revenue from nonrefundable upfront fees expected to be recognized in fiscal 2022 | 4,982 | 4,982 | ||
Deferred revenue from nonrefundable upfront fees expected to be recognized in fiscal 2023 | 6,127 | 6,127 | ||
Deferred revenue from nonrefundable upfront fees expected to be recognized in fiscal 2024 and thereafter | $ 1,293 | $ 1,293 | ||
Maximum | ||||
Revenue | ||||
Amortization period of nonrefundable upfront implementation fees | 24 months |
Revenue - Deferred Contract Cos
Revenue - Deferred Contract Costs (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Deferred contract costs | ||||
Amortization period of capitalized contract costs | 7 years | 7 years | ||
Beginning Balance | $ 241,679 | $ 181,474 | $ 214,893 | $ 158,043 |
Capitalized Costs | 36,081 | 26,187 | 86,787 | 67,402 |
Amortization | (13,445) | (9,997) | (37,365) | (27,781) |
Ending Balance | 264,315 | 197,664 | 264,315 | 197,664 |
Costs to obtain a new contract | ||||
Deferred contract costs | ||||
Beginning Balance | 155,564 | 125,817 | 145,718 | 113,575 |
Capitalized Costs | 22,256 | 17,315 | 48,922 | 43,026 |
Amortization | (9,182) | (7,390) | (26,002) | (20,859) |
Ending Balance | 168,638 | 135,742 | 168,638 | 135,742 |
Costs to fulfill a contract | ||||
Deferred contract costs | ||||
Beginning Balance | 86,115 | 55,657 | 69,175 | 44,468 |
Capitalized Costs | 13,825 | 8,872 | 37,865 | 24,376 |
Amortization | (4,263) | (2,607) | (11,363) | (6,922) |
Ending Balance | $ 95,677 | $ 61,922 | $ 95,677 | $ 61,922 |
Revenue - Remaining Performance
Revenue - Remaining Performance Obligations (Details) $ in Thousands | Mar. 31, 2022USD ($) |
Remaining Performance Obligations | |
Minimum value of unsatisfied performance obligations on term-based contracts | $ 49,698 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01 | |
Remaining Performance Obligations | |
Remaining performance obligation period | 24 months |
Business Combinations (Details)
Business Combinations (Details) - USD ($) $ in Thousands | Jan. 18, 2022 | Aug. 31, 2021 | Mar. 31, 2022 | Jun. 30, 2021 |
Business Combinations | ||||
Goodwill | $ 102,183 | $ 33,650 | ||
Blue Marble | ||||
Business Combinations | ||||
Cash consideration | $ 60,961 | |||
Goodwill | 34,776 | |||
Other assets acquired | 2,659 | |||
Liabilities assumed | (1,874) | |||
Total purchase price | 60,961 | |||
Blue Marble | Proprietary technology | ||||
Business Combinations | ||||
Intangible assets | 21,200 | |||
Blue Marble | Client relationships | ||||
Business Combinations | ||||
Intangible assets | 3,000 | |||
Blue Marble | Trade names | ||||
Business Combinations | ||||
Intangible assets | $ 1,200 | |||
Cloudsnap, Inc | ||||
Business Combinations | ||||
Cash consideration | $ 50,002 | |||
Goodwill | 33,757 | |||
Other assets acquired | 3,041 | |||
Liabilities assumed | (2,596) | |||
Total purchase price | 50,002 | |||
Cloudsnap, Inc | Proprietary technology | ||||
Business Combinations | ||||
Intangible assets | $ 15,800 |
Balance Sheet Information - All
Balance Sheet Information - Allowance for Credit Losses for Accounts Receivable, Capitalized Internal-Use Software and Property, Plant and Equipment (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | Jun. 30, 2021 | |
Activity in the allowance for credit losses | |||||
Beginning balance | $ 800 | ||||
Charged to expense | 238 | $ 213 | |||
Write-offs | (183) | ||||
Ending balance | $ 855 | 855 | |||
Capitalized internal-use software and accumulated amortization | |||||
Capitalized internal-use software | 182,140 | 182,140 | $ 150,922 | ||
Accumulated amortization | (124,427) | (124,427) | (105,904) | ||
Capitalized internal-use software, net | 57,713 | 57,713 | 45,018 | ||
Property and equipment, net | |||||
Property and equipment, gross | 133,284 | 133,284 | 122,589 | ||
Accumulated depreciation | (69,280) | (69,280) | (62,754) | ||
Property and equipment, net | 64,004 | 64,004 | 59,835 | ||
Depreciation expense | 4,098 | $ 3,966 | 11,914 | 11,985 | |
Changes in Goodwill | |||||
Beginning balance | 33,650 | ||||
Additions attributable to acquisitions | 68,533 | ||||
Ending balance | 102,183 | 102,183 | |||
Cost of revenues | |||||
Capitalized internal-use software and accumulated amortization | |||||
Amortization of capitalized internal-use software | 6,308 | $ 6,005 | 18,523 | $ 17,273 | |
Office equipment | |||||
Property and equipment, net | |||||
Property and equipment, gross | 4,365 | 4,365 | 5,211 | ||
Computer equipment | |||||
Property and equipment, net | |||||
Property and equipment, gross | 54,172 | 54,172 | 45,420 | ||
Furniture and fixtures | |||||
Property and equipment, net | |||||
Property and equipment, gross | 12,791 | 12,791 | 13,104 | ||
Software | |||||
Property and equipment, net | |||||
Property and equipment, gross | 8,278 | 8,278 | 6,641 | ||
Leasehold improvements | |||||
Property and equipment, net | |||||
Property and equipment, gross | 47,255 | 47,255 | 46,814 | ||
Time clocks rented by clients | |||||
Property and equipment, net | |||||
Property and equipment, gross | $ 6,423 | $ 6,423 | $ 5,399 |
Balance Sheet Information - Int
Balance Sheet Information - Intangible Assets and Accrued Expenses (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | Jun. 30, 2021 | |
Amortizable intangible assets | |||||
Amortizable intangible assets, gross | $ 68,569 | $ 68,569 | $ 27,369 | ||
Accumulated amortization | (20,324) | (20,324) | (14,342) | ||
Intangible assets, net | 48,245 | 48,245 | 13,027 | ||
Amortization expense for acquired intangible assets | 2,630 | $ 1,028 | 5,982 | $ 2,812 | |
Future amortization expense for acquired intangible assets | |||||
Remainder of fiscal 2022 | 2,770 | 2,770 | |||
Fiscal 2023 | 10,948 | 10,948 | |||
Fiscal 2024 | 9,943 | 9,943 | |||
Fiscal 2025 | 8,888 | 8,888 | |||
Fiscal 2026 | 7,269 | 7,269 | |||
Thereafter | 8,427 | 8,427 | |||
Intangible assets, net | 48,245 | 48,245 | 13,027 | ||
Components of accrued expenses | |||||
Accrued payroll and personnel costs | 67,965 | 67,965 | 73,969 | ||
Operating lease liabilities | 8,270 | 8,270 | 7,549 | ||
Deferred revenue | 14,326 | 14,326 | 9,442 | ||
Other | 18,259 | 18,259 | 12,149 | ||
Total accrued expenses | 108,820 | 108,820 | 103,109 | ||
Proprietary technology | |||||
Amortizable intangible assets | |||||
Amortizable intangible assets, gross | 43,129 | $ 43,129 | 6,129 | ||
Weighted average useful life (years) | 6 years | ||||
Client relationships | |||||
Amortizable intangible assets | |||||
Amortizable intangible assets, gross | 22,200 | $ 22,200 | 19,200 | ||
Weighted average useful life (years) | 7 years 9 months 18 days | ||||
Non-solicitation agreements | |||||
Amortizable intangible assets | |||||
Amortizable intangible assets, gross | 1,600 | $ 1,600 | 1,600 | ||
Weighted average useful life (years) | 3 years 1 month 6 days | ||||
Trade names | |||||
Amortizable intangible assets | |||||
Amortizable intangible assets, gross | $ 1,640 | $ 1,640 | $ 440 | ||
Weighted average useful life (years) | 5 years |
Corporate Investments and Fun_3
Corporate Investments and Funds Held For Clients - Reconciliation (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Jun. 30, 2021 | Mar. 31, 2021 |
Corporate Investments and Funds Held for Clients | |||
Amortized cost of cash and cash equivalents | $ 96,465 | $ 202,287 | |
Fair value of cash and cash equivalents | 96,465 | 202,287 | $ 175,453 |
Amortized cost of funds held for clients' cash and cash equivalents | 4,176,903 | 1,743,594 | |
Fair value of funds held for clients' cash and cash equivalents | 4,176,903 | 1,743,594 | $ 2,019,089 |
Available-for-sale securities: | |||
Amortized cost | 149,773 | 20,452 | |
Gross unrealized gains | 1 | 87 | |
Gross unrealized losses | (2,110) | 0 | |
Fair value | 147,664 | 20,539 | |
Total investments at amortized cost | 4,423,141 | 1,966,333 | |
Total investments gross unrealized gains | 1 | 87 | |
Total investments gross unrealized losses | (2,110) | 0 | |
Total investments | 4,421,032 | 1,966,420 | |
Commercial paper | |||
Available-for-sale securities: | |||
Amortized cost | 49,440 | ||
Gross unrealized gains | 0 | ||
Gross unrealized losses | (113) | ||
Fair value | 49,327 | ||
Corporate bonds | |||
Available-for-sale securities: | |||
Amortized cost | 54,607 | 13,390 | |
Gross unrealized gains | 1 | 70 | |
Gross unrealized losses | (1,289) | 0 | |
Fair value | 53,319 | 13,460 | |
Asset-backed securities | |||
Available-for-sale securities: | |||
Amortized cost | 8,082 | 7,062 | |
Gross unrealized gains | 0 | 17 | |
Gross unrealized losses | (135) | 0 | |
Fair value | 7,947 | 7,079 | |
Certificates of deposit | |||
Available-for-sale securities: | |||
Amortized cost | 23,785 | ||
Gross unrealized gains | 0 | ||
Gross unrealized losses | (50) | ||
Fair value | 23,735 | ||
U.S. treasury securities | |||
Available-for-sale securities: | |||
Amortized cost | 4,036 | ||
Gross unrealized gains | 0 | ||
Gross unrealized losses | (90) | ||
Fair value | 3,946 | ||
U.S government agency securities | |||
Available-for-sale securities: | |||
Amortized cost | 7,000 | ||
Gross unrealized gains | 0 | ||
Gross unrealized losses | (372) | ||
Fair value | 6,628 | ||
Other | |||
Available-for-sale securities: | |||
Amortized cost | 2,823 | ||
Gross unrealized gains | 0 | ||
Gross unrealized losses | (61) | ||
Fair value | $ 2,762 | ||
Corporate investments | |||
Available-for-sale securities: | |||
Fair value | 4,456 | ||
Funds held for clients | |||
Available-for-sale securities: | |||
Fair value | $ 16,083 |
Corporate Investments and Fun_4
Corporate Investments and Funds Held For Clients - Classification (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | Jun. 30, 2021 | |
Corporate Investments and Funds Held for Clients | |||||
Cash and cash equivalents | $ 96,465 | $ 175,453 | $ 96,465 | $ 175,453 | $ 202,287 |
Corporate investments | 0 | 0 | 4,456 | ||
Funds held for clients | 4,324,567 | 4,324,567 | 1,759,677 | ||
Total investments | 4,421,032 | 4,421,032 | 1,966,420 | ||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (2,110) | (2,110) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | 145,132 | 145,132 | |||
Available-for-sale securities in unrealized loss positions | $ 0 | ||||
Unrealized losses on available-for-sale securities in continuous unrealized loss positions for greater than 12 months | 0 | 0 | |||
Credit impairment losses | 0 | 0 | 0 | 0 | |
Realized gains or losses | 0 | $ 0 | 0 | $ 0 | |
Commercial paper | |||||
Corporate Investments and Funds Held for Clients | |||||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (113) | (113) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | 49,327 | 49,327 | |||
Corporate bonds | |||||
Corporate Investments and Funds Held for Clients | |||||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (1,289) | (1,289) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | 51,909 | 51,909 | |||
Asset-backed securities | |||||
Corporate Investments and Funds Held for Clients | |||||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (135) | (135) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | 7,826 | 7,826 | |||
Certificates of deposit | |||||
Corporate Investments and Funds Held for Clients | |||||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (50) | (50) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | 22,734 | 22,734 | |||
U.S. treasury securities | |||||
Corporate Investments and Funds Held for Clients | |||||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (90) | (90) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | 3,946 | 3,946 | |||
U.S government agency securities | |||||
Corporate Investments and Funds Held for Clients | |||||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (372) | (372) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | 6,628 | 6,628 | |||
Other | |||||
Corporate Investments and Funds Held for Clients | |||||
Gross unrealized losses on available-for-sale securities in unrealized loss positions for less than 12 months | (61) | (61) | |||
Fair value of available-for-sale securities in unrealized loss positions for less than 12 months | $ 2,762 | $ 2,762 |
Corporate Investments and Fun_5
Corporate Investments and Funds Held For Clients - Maturities (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Jun. 30, 2021 |
Expected maturities of available-for-sale securities, amortized cost | ||
One year or less | $ 98,775 | |
One year to two years | 26,988 | |
Two years to three years | 20,000 | |
Three years to five years | 4,010 | |
Total available-for-sale securities | 149,773 | $ 20,452 |
Expected maturities of available-for-sale securities, fair value | ||
One year or less | 98,392 | |
One year to two years | 26,369 | |
Two years to three years | 19,138 | |
Three years to five years | 3,765 | |
Total available-for-sale securities | $ 147,664 | $ 20,539 |
Fair Value Measurement (Details
Fair Value Measurement (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Jun. 30, 2021 | Mar. 31, 2021 |
Fair value measurement | |||
Cash and cash equivalents | $ 96,465 | $ 202,287 | $ 175,453 |
Funds held for clients' cash and cash equivalents | 4,176,903 | 1,743,594 | $ 2,019,089 |
Available-for-sale securities: | |||
Total available-for-sale securities | 147,664 | 20,539 | |
Total investments | 4,421,032 | 1,966,420 | |
Level 3 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 0 | 0 | |
Level 1 | |||
Fair value measurement | |||
Cash and cash equivalents | 96,465 | 202,287 | |
Funds held for clients' cash and cash equivalents | 4,176,903 | 1,743,594 | |
Available-for-sale securities: | |||
Total investments | 4,273,368 | 1,945,881 | |
Level 2 | |||
Fair value measurement | |||
Cash and cash equivalents | 0 | 0 | |
Funds held for clients' cash and cash equivalents | 0 | 0 | |
Available-for-sale securities: | |||
Total available-for-sale securities | 147,664 | 20,539 | |
Total investments | 147,664 | 20,539 | |
Commercial paper | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 49,327 | ||
Commercial paper | Level 2 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 49,327 | ||
Corporate bonds | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 53,319 | 13,460 | |
Corporate bonds | Level 2 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 53,319 | 13,460 | |
Asset-backed securities | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 7,947 | 7,079 | |
Asset-backed securities | Level 2 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 7,947 | $ 7,079 | |
Certificates of deposit | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 23,735 | ||
Certificates of deposit | Level 2 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 23,735 | ||
U.S. treasury securities | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 3,946 | ||
U.S. treasury securities | Level 2 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 3,946 | ||
U.S government agency securities | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 6,628 | ||
U.S government agency securities | Level 2 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 6,628 | ||
Other | |||
Available-for-sale securities: | |||
Total available-for-sale securities | 2,762 | ||
Other | Level 2 | |||
Available-for-sale securities: | |||
Total available-for-sale securities | $ 2,762 |
Debt (Details)
Debt (Details) - USD ($) $ in Thousands | Mar. 31, 2022 | Jun. 30, 2021 | Jul. 31, 2019 | Mar. 31, 2022 | Mar. 31, 2021 |
Debt | |||||
Borrowed and repaid under credit facility | $ 50,000 | $ 0 | |||
Five-year revolving credit agreement | Senior secured debt | |||||
Debt | |||||
Term of credit agreement | 5 years | ||||
Maximum borrowing capacity | $ 250,000 | ||||
Maximum borrowing capacity, subject to additional lender commitments and satisfaction of other requirements | $ 375,000 | ||||
Borrowed and repaid under credit facility | $ 0 | $ 0 | |||
Five-year revolving credit agreement | Senior secured debt | Minimum | |||||
Debt | |||||
Interest coverage ratio | 3 | ||||
Five-year revolving credit agreement | Senior secured debt | Maximum | |||||
Debt | |||||
Net total leverage ratio | 4 | ||||
Net senior secured leverage ratio | 3.50 | ||||
Five-year revolving credit agreement | Senior secured debt | London Interbank Offered Rate (LIBOR) | Minimum | |||||
Debt | |||||
Margin on base rate | 0.875% | ||||
Five-year revolving credit agreement | Senior secured debt | London Interbank Offered Rate (LIBOR) | Maximum | |||||
Debt | |||||
Margin on base rate | 1.375% | ||||
Five-year revolving credit agreement | Senior secured debt | Adjusted base rate | Minimum | |||||
Debt | |||||
Margin on base rate | 0.00% | ||||
Five-year revolving credit agreement | Senior secured debt | Adjusted base rate | Maximum | |||||
Debt | |||||
Margin on base rate | 0.375% |
Stock-Based Compensation - Gene
Stock-Based Compensation - General Information (Details) - shares shares in Thousands | Jan. 01, 2022 | Mar. 31, 2022 |
Equity Incentive Plans | ||
Equity Incentive Plans | ||
Actual increase in number of shares of common stock reserved for issuance (in shares) | 2,400 | |
Number of shares of common stock reserved for issuance (in shares) | 14,391 | |
Number of shares allocated but not yet issued that are subject to outstanding options or awards (in shares) | 1,999 | |
2008 Plan | ||
Equity Incentive Plans | ||
Awards issued (in shares) | 0 | |
Awards issuable (in shares) | 0 | |
2014 Incentive Plan | ||
Equity Incentive Plans | ||
Potential number of additional shares available for grant each year (as a percent) | 4.50% | |
Actual increase in number of shares of common stock reserved for issuance (in shares) | 2,400 |
Stock-Based Compensation - Ince
Stock-Based Compensation - Incentive Plans Activity (Details) - Equity Incentive Plans shares in Thousands | 9 Months Ended |
Mar. 31, 2022shares | |
Shares Available for Grant | |
Beginning balance (in shares) | 10,312 |
January 1, 2022 Evergreen provision increase (in shares) | 2,400 |
RSUs granted (in shares) | (614) |
MSUs granted (in shares) | (47) |
Shares withheld in net settlement for taxes and/or exercise price (in shares) | 280 |
Forfeitures (in shares) | 120 |
Shares removed (in shares) | (59) |
Ending balance (in shares) | 12,392 |
Stock-Based Compensation - Comp
Stock-Based Compensation - Compensation Expense (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Benefit Plans | ||||
Stock-based compensation expense capitalized in internal-use software costs | $ 1,886 | $ 652 | $ 5,312 | $ 1,949 |
Total stock-based compensation expense | 24,395 | 16,011 | 70,197 | 46,947 |
Cost of revenues | ||||
Benefit Plans | ||||
Total stock-based compensation expense | 2,936 | 1,972 | 8,860 | 5,773 |
Sales and marketing | ||||
Benefit Plans | ||||
Total stock-based compensation expense | 5,119 | 3,938 | 15,994 | 11,783 |
Research and development | ||||
Benefit Plans | ||||
Total stock-based compensation expense | 4,855 | 2,602 | 13,963 | 7,570 |
General and administrative | ||||
Benefit Plans | ||||
Total stock-based compensation expense | 11,485 | 7,499 | 31,380 | 21,821 |
Modified performance-based restricted stock unit awards | ||||
Benefit Plans | ||||
Total stock-based compensation expense | $ 1,819 | $ 1,776 | $ 4,877 | $ 4,560 |
Stock-Based Compensation - Stoc
Stock-Based Compensation - Stock Option Activity (Details) - Stock options - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | Jun. 30, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 |
Options Outstanding, Number of Shares | |||||
Beginning balance (in shares) | 765 | ||||
Options granted (in shares) | 0 | ||||
Options exercised (in shares) | (204) | ||||
Ending balance (in shares) | 765 | 561 | 561 | ||
Options Outstanding, Weighted average exercise price | |||||
Beginning balance (in dollars per share) | $ 16.06 | ||||
Options exercised (in dollars per share) | 9.69 | ||||
Ending balance (in dollars per share) | $ 16.06 | $ 18.37 | $ 18.37 | ||
Options Additional Disclosures | |||||
Weighted average remaining contractual term (years) | 2 years 4 months 24 days | 1 year 9 months 18 days | |||
Weighted average remaining contractual term of options vested and exercisable at the end of the period (years) | 1 year 9 months 18 days | ||||
Aggregate intrinsic value at the beginning of the period | $ 133,550 | ||||
Aggregate intrinsic value at the end of the period | $ 133,550 | $ 105,094 | $ 105,094 | ||
Options vested and exercisable at the end of the period (in shares) | 561 | 561 | |||
Options vested and exercisable at the end of the period, weighted average exercise price (in dollars per share) | $ 18.37 | $ 18.37 | |||
Options vested and exercisable, aggregate intrinsic value | $ 105,094 | $ 105,094 | |||
Total intrinsic value of options exercised | $ 1,819 | $ 20,975 | $ 49,446 | $ 58,252 |
Stock-Based Compensation - RSU
Stock-Based Compensation - RSU activity (Details) - Restricted stock units $ / shares in Units, shares in Thousands, $ in Thousands | 9 Months Ended |
Mar. 31, 2022USD ($)$ / sharesshares | |
RSUs Outstanding, Units | |
Beginning balance (in shares) | shares | 1,388 |
RSUs granted (in shares) | shares | 614 |
RSUs vested (in shares) | shares | (549) |
RSUs forfeited (in shares) | shares | (115) |
Ending balance (in shares) | shares | 1,338 |
RSUs Outstanding, Weighted average grant date fair value | |
Beginning balance (in dollars per share) | $ / shares | $ 100.33 |
RSUs granted (in dollars per share) | $ / shares | 247.98 |
RSUs vested (in dollars per share) | $ / shares | 84.83 |
RSUs forfeited (in dollars per share) | $ / shares | 160.61 |
Ending balance (in dollars per share) | $ / shares | $ 169.40 |
Unrecognized Compensation Costs Not Yet Recognized, Net of Estimated Forfeitures [Abstract] | |
Total unrecognized compensation cost, net of estimated forfeitures related to unvested RSUs | $ | $ 113,191 |
Weighted average period to recognize unrecognized compensation cost (in years) | 1 year 10 months 24 days |
Minimum | |
Equity Incentive Plans | |
Vesting period | 3 years |
Maximum | |
Equity Incentive Plans | |
Vesting period | 4 years |
Stock-Based Compensation - MSU
Stock-Based Compensation - MSU activity (Details) - Market share units shares in Thousands | 9 Months Ended |
Mar. 31, 2022$ / sharesshares | |
Equity Incentive Plans | |
Vesting period | 3 years |
Percentage of target number of shares subject to each MSU | 200.00% |
MSUs Outstanding, Units | |
Beginning balance (in shares) | shares | 58 |
MSUs granted (in shares) | shares | 48 |
MSUs forfeited (in shares) | shares | (5) |
Ending balance (in shares) | shares | 101 |
MSUs Outstanding, Weighted average grant date fair value | |
Beginning balance (in dollars per share) | $ / shares | $ 178.04 |
MSUs granted (in dollars per share) | $ / shares | 361.02 |
MSUs forfeited (in dollars per share) | $ / shares | 178.04 |
Ending balance (in dollars per share) | $ / shares | $ 263.83 |
Stock-Based Compensation - MS_2
Stock-Based Compensation - MSU Information (Details) - Market share units - USD ($) $ in Thousands | 9 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2021 | |
Valuation assumptions: | ||
Expected dividend yield | 0.00% | 0.00% |
Expected volatility | 52.00% | |
Expected term (years) | 3 years 14 days | |
Risk‑free interest rate | 0.18% | |
Unrecognized Compensation Costs Not Yet Recognized, Net of Estimated Forfeitures [Abstract] | ||
Total unrecognized compensation cost, net of estimated forfeitures related to unvested MSUs | $ 16,131 | |
Weighted average period to recognize unrecognized compensation cost (in years) | 2 years 2 months 12 days | |
Minimum | ||
Valuation assumptions: | ||
Expected volatility | 47.40% | |
Expected term (years) | 2 years 11 months 1 day | |
Risk‑free interest rate | 0.43% | |
Maximum | ||
Valuation assumptions: | ||
Expected volatility | 47.50% | |
Expected term (years) | 3 years 14 days | |
Risk‑free interest rate | 0.47% |
Income Taxes (Details)
Income Taxes (Details) | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | ||||
Effective tax rate for the period (as a percent) | 26.00% | 5.40% | (16.40%) | (22.50%) |
U.S. federal income tax rate (as a percent) | 21.00% | 21.00% | 21.00% | 21.00% |
Net Income Per Share (Details)
Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2022 | Mar. 31, 2021 | Mar. 31, 2022 | Mar. 31, 2021 | |
Numerator: | ||||
Net income | $ 34,846 | $ 36,834 | $ 75,631 | $ 58,936 |
Weighted-average shares used in computing net income per share: | ||||
Basic (in shares) | 55,114 | 54,415 | 54,996 | 54,244 |
Weighted-average effect of potentially dilutive shares: | ||||
Employee stock options, restricted stock units, market share units and employee stock purchase plan shares (in shares) | 1,253 | 1,999 | 1,441 | 2,094 |
Diluted (in shares) | 56,367 | 56,414 | 56,437 | 56,338 |
Net income per share: | ||||
Basic (in dollars per share) | $ 0.63 | $ 0.68 | $ 1.38 | $ 1.09 |
Diluted (in dollars per share) | $ 0.62 | $ 0.65 | $ 1.34 | $ 1.05 |
Anti-dilutive securities excluded (in shares) | 81 | 1 | 78 | 13 |
Market share units | ||||
Net income per share: | ||||
Anti-dilutive securities excluded (in shares) | 19 | 0 | 19 | 0 |
Restricted stock units | ||||
Net income per share: | ||||
Anti-dilutive securities excluded (in shares) | 62 | 1 | 59 | 13 |